scholarly article | Q13442814 |
P2093 | author name string | P J Berry | |
A K Charles | |||
K W Brown | |||
P2860 | cites work | A new theory on cancer-inducing mechanism | Q24564810 |
A genetic model for colorectal tumorigenesis | Q27860582 | ||
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor study | Q28288004 | ||
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21 | Q30338283 | ||
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor | Q34189532 | ||
The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 | ||
Mutation and cancer: a model for Wilms' tumor of the kidney | Q34207334 | ||
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development | Q34240417 | ||
Epidemiology of Wilms tumor | Q34305834 | ||
Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination | Q35165770 | ||
Microsatellites for linkage analysis of genetic traits | Q35750385 | ||
Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology | Q36108223 | ||
Wilms' tumour associated with deep cystic nephroma-like changes: three cases of a putative Wilms' tumour precursor | Q37168302 | ||
Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor | Q37874427 | ||
Multifocal nephroblastic neoplasia | Q40166927 | ||
RNA Processing: Wilms' tumour — the splicing connection? | Q40427898 | ||
Dinucleotide repeat polymorphisms at the D16S260, D16S261, D16S265, D16S266, and D16S267 loci. | Q40518342 | ||
Towards a genetic basis for kidney development. | Q40578169 | ||
The genetics of Wilms' tumor--a case of disrupted development | Q40614052 | ||
Genetic events in the development of Wilms' tumor | Q40681250 | ||
Epidemiologic features of Wilms tumor | Q40964142 | ||
Histopathology of childhood renal tumors | Q40964148 | ||
Screening for Wilms tumor in high-risk individuals. | Q40964154 | ||
The WT1 Wilms' tumor suppressor gene: how much do we really know? | Q40992673 | ||
Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group | Q41036122 | ||
Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome | Q41086727 | ||
Recurrent renal cell carcinoma arising in wilms' tumor | Q41822440 | ||
Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis | Q41855851 | ||
Mechanisms of loss of heterozygosity in retinoblastoma | Q44552335 | ||
Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor | Q48139314 | ||
Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. | Q52068403 | ||
Papillary Wilms' tumour with carcinoma-like foci and renal cell carcinoma in childhood. | Q54453277 | ||
Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis | Q57252309 | ||
Nephrogenic Rest and Mesoblastic Nephroma | Q57727479 | ||
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome | Q58236969 | ||
Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis | Q62810762 | ||
Constitutional and somatic mutations in theWTI gene in wilms' tumor patients | Q62810830 | ||
Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome | Q67510310 | ||
A third Wilms' tumor locus on chromosome 16q | Q67848748 | ||
Nonlinkage of 16q markers to familial predisposition to Wilms' tumor | Q67885652 | ||
Simpson-Golabi-Behmel syndrome: an X-linked encephalo-tropho-schisis syndrome | Q67945209 | ||
Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis | Q69350985 | ||
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours | Q69844381 | ||
Obstructive uropathy, renal dysplasia and nodular renal blastema: is there a relationship to Wilms tumor? | Q70093620 | ||
Genetic mosaicism in normal tissues of Wilms' tumour patients | Q70457181 | ||
Molecular genetics of Wilms tumor | Q70978673 | ||
Nephrogenic rest associated with a mesoblastic nephroma--what does it tell us? | Q70992567 | ||
Epigenetics and human disease | Q71031916 | ||
Familial Wilms' tumor: a descriptive study | Q71580253 | ||
Non-11p constitutional chromosome abnormalities in Wilms' tumor patients | Q72118653 | ||
Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess | Q72132779 | ||
Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations | Q72161523 | ||
Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome | Q72373963 | ||
Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour | Q72751031 | ||
Germline and somatic abnormalities of chromosome 7 in Wilms' tumor | Q72789607 | ||
Beckwith-Wiedemann syndrome | Q72819474 | ||
Comparative genomic hybridization analysis of Wilms tumors | Q73668835 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | genetic event | Q115865817 |
P304 | page(s) | 991-1000 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development | |
P478 | volume | 153 |
Q54203616 | A causal mechanism for childhood acute lymphoblastic leukaemia. |
Q40911210 | Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors |
Q38675275 | Bilateral Wilms tumour: a review of clinical and molecular features |
Q52106354 | Bilateral noncystic renal dysplasia in a Wistar-rat |
Q54272965 | Bilateral wilms tumor with TP53-related anaplasia. |
Q50108842 | Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene |
Q35163343 | Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour |
Q35307434 | Extrarenal nephroblastomatosis in children: a report of two cases |
Q83831222 | Fine needle aspiration cytology of cystic partially differentiated nephroblastoma of the kidney |
Q30945124 | Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor |
Q57636682 | Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes |
Q85902702 | Glypican 3 overexpression in primary and metastatic Wilms tumors |
Q35668754 | Insights into the physiological role of WT1 from studies of genetically modified mice |
Q37149909 | Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications |
Q42655265 | KIT, PDGFRalpha and EGFR analysis in nephroblastoma |
Q57339656 | Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis |
Q85843571 | Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India |
Q36621144 | Loss of heterozygosity at 7p in Wilms' tumour development |
Q74095463 | Low frequency of genetic lesions in Wilms tumors by representational difference analysis |
Q64970878 | Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1. |
Q81247333 | Nephroblastomatosis and loss of WT1 expression associated with trisomy 13 |
Q51352089 | Nephrogenic rest within a lipomyelomeningocele in a patient with unilateral renal agenesis. |
Q38850325 | Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience |
Q38080737 | Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms |
Q50080798 | Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology |
Q57727294 | Perilobar Nephrogenic Rests and Chromosome 22 |
Q42056082 | Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors |
Q79105079 | Protocol for the Examination of Specimens From Patients With Wilms Tumor (Nephroblastoma) or Other Renal Tumors of Childhood |
Q41809711 | Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies |
Q42685351 | The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour |
Q91297749 | The genetic changes of Wilms tumour |
Q24320196 | WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis |
Q33727614 | Wilms' tumor and related abnormalities in the fetus and newborn |
Q36234726 | Wilms' tumour: connecting tumorigenesis and organ development in the kidney |
Q81563846 | [Nephrogenic rests and nephroblastomatosis] |
Search more.